Oral contraceptive pills for men: Notable success in clinical trials

1 min read
Read later

Representative Image | Photo: PTI

Thrissur: A team of scientists shared information regarding the experiments of oral contraceptive pills for men, during the annual conference of Endocrine Society held at Atlanta in Georgia. They successfully conducted a set of clinical trials of two different medicine compounds.

It has been hinted that the pills which yielded 90 per cent result in the initial trial endured its efficiency in the second trial also. The clinical tests began following the 99 per cent positive result obtained in the experiments on rodents. 96 men participated in the first phase of experiments. When compared to those who had not consumed any pills, the sperm count was found less for the men who had intaken 200 milligram pills daily for 28 days. The sperm count was even lower for the men who consumed 400 milligram pills daily.

No side effects were reported in the men who had taken the pills. This urged the team to enter into the next level of trials. It will be experimented on more men. If the results of the third phase of the trial turn successful, the pills will become available in the market.

Add Comment
Related Topics

Get daily updates from Mathrubhumi.com

Disclaimer: Kindly avoid objectionable, derogatory, unlawful and lewd comments, while responding to reports. Such comments are punishable under cyber laws. Please keep away from personal attacks. The opinions expressed here are the personal opinions of readers and not that of Mathrubhumi.

Moungi G. Bawendi, Louis E. Brus and Alexei I. Ekimov

2 min

3 scientists win Nobel Prize in chemistry for their work on tiny quantum dots

Oct 4, 2023

Pierre Agostini, Ferenc Krausz and Anne L’Huillier, the Nobel Prize, 2023 winners in physics

2 min

Agostini, Krausz and L’Huillier win physics Nobel for looking at electrons in fractions of seconds

Oct 3, 2023

Chandrayaan 3

1 min

Chandrayaan-3: Lander Module health normal, gets closer to Moon; sends images

Aug 18, 2023